# Prediction Medical Device for Rheumatoid Arthritis (PREDIRA)

> **NCT04147026** · NA · UNKNOWN · sponsor: **Hospital San Carlos, Madrid** · enrollment: 180 (estimated)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **DEVICE:** SinnoTest®
- **OTHER:** Biotherapy prescription without SinnoTest® software

## Key facts

- **NCT ID:** NCT04147026
- **Lead sponsor:** Hospital San Carlos, Madrid
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-16
- **Primary completion:** 2020-07-01
- **Final completion:** 2021-01-01
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2020-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04147026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04147026, "Prediction Medical Device for Rheumatoid Arthritis (PREDIRA)". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT04147026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*